Filtered By:
Source: American Heart Journal
Drug: Cilostazol
Procedure: Percutaneous Coronary Intervention
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Addition of cilostazol to aspirin therapy for secondary prevention of cardiovascular and cerebrovascular disease in patients undergoing percutaneous coronary intervention: A randomized, open-label trial
Conclusions In patients who underwent coronary stent implantation, the addition of cilostazol to aspirin therapy was associated with lower rates of cardiovascular and cerebrovascular events at 2 years compared with aspirin monotherapy.
Source: American Heart Journal - January 12, 2016 Category: Cardiology Source Type: research
